百靈佳殷格翰是一家全球領先的生物製藥企業，包含人用處方用藥與動物保健兩大業務。作為產業中研發投入最高的公司之一，百靈佳殷格翰致力於研究突破性療法，解決巨大而未被滿足的醫療需求。百靈佳殷格翰自1885年成立以來一直是一家獨立的家族企業，始終著眼長遠發展，並將永續發展嵌入價值鏈。公司在全球有超過5.3萬名員工，服務逾130個市場，致力於打造一個更健康、更永續、更公平的未來。更多詳情，請訪問：www.boehringer-ingelheim.com/tw

「台灣百靈佳殷格翰股份有限公司」與「台灣百靈佳殷格翰動物事業股份有限公司」是百靈佳殷格翰在台子公司，成立於1975年，迄今已逾49年，目前在台灣北、中、南共設有3個辦公室，員工近350人。人類處方用藥及動物保健是公司的核心業務，人類處方用藥持續在呼吸道疾病、癌症、糖尿病、心血管疾病、中風、巴金森病、纖維化疾病等領域幫助更多病患；動物保健方面，我們持續在內外寄生蟲預防、心臟疾病、慢性腎病與疼痛治療上協助伴侶動物與其照顧者，更也在許多疾病上協助經濟動物產業的畜場主人，如豬隻環狀病毒及藍耳病、家禽馬立克病及新城雞病…等。

了解更多百靈佳殷格翰：
www.boehringer-ingelheim.com (總公司官網)
www.boehringer-ingelheim.com/tw (台灣官網)
www.facebook.com/1975BITW (台灣百靈佳殷格翰社會創新平台)
http://annualreport.boehringer-ingelheim.com (2023年企業白皮書)
https://line.me/R/ti/p/%40lxh2761d (台灣百靈佳殷格翰LINE@官方帳號)
https://bit.ly/3Ux6p8B  (百靈佳殷格翰 社會行動全攻略 暨 全媒體地圖)

https://bit.ly/4d3M1To (「永續發展 – 世代經營」計畫宣言)

*資料保存期限：2024/4/18 至2025年度記者會

Boehringer Ingelheim

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in Research and Development, the company focuses on developing innovative therapies in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. More than 53,500 employees serve over 130 markets to build a healthier, more sustainable, and equitable tomorrow. Learn more at www.boehringer-ingelheim.com.

Boehringer Ingelheim, Taiwan has served in Taiwan since 1975 as a healthy issue solution provider with more than 350 employees and 3 different offices located in north, central and south Taiwan. With core business in Human Pharm and Animal Health, we support patients in the area of the respiratory, oncology, diabetes, cardiovascular, stroke, Parkinson's disease, fibrosis disease and more. We support companion animals and their owners in parasite prevention and the treatment for heart disease and chronic kidney disease, also support livestock farmer in serval disease prevention, such as porcine reproductive and respiratory syndrome, Newcastle Disease and more.

More information about Boehringer Ingelheim:
www.boehringer-ingelheim.com (Corporate Website)
www.boehringer-ingelheim.com/tw (Taiwan Website)
www.facebook.com/1985BITW (Social Innovation Facebook Page)
http://annualreport.boehringer-ingelheim.com (2023 Annual Report)
https://line.me/R/ti/p/%40lxh2761d (LINE@ Official account)
https://bit.ly/3Ux6p8B  (Media Map)

https://bit.ly/4d3M1To (Sustainable Development - For Generations)

* To be used from April 16, 2024 until the Annual Results Press Conference in 2025